ATG4B and chronic myelogenous leukemia, BCR-ABL1 positive: In chronic myeloid leukemia (CML), miR-34a impairs the survival of CD34+ hematopoietic stem/progenitor cells by targeting ATG4B (Figure 4), a core autophagy protein (Rothe et al., 2014).